F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 46,048 shares at $23.19 ($1.0M) on 2022-10-06, disclosed to the SEC on 2022-10-07.
Open-market sale of $1.0M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.57 | 16,274 | $367K | 35.1% |
| 2 | $22.57 | 16,274 | $367K | 35.1% |
| 3 | $23.19 | 13,500 | $313K | 29.9% |
| Total | $22.75 avg | 46,048 | $1.0M | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |